Enhanced urinary excretion of cGMP in liver cirrhosis: Relationship to hemodynamic changes, neurohormonal activation, and urinary sodium excretion

Digestive Diseases and Sciences

Volumn 42, Issue 7, 1997, Pages 1416-1420

  Fernandez Rodriguez C M ^b   Prieto, J ^a   Quiroga, J ^b   Zozaya, J M ^b   Andrade, A ^b   Rodriguez Ortigosa, C ^b  

^a UNIVERSITY CLINIC OF NAVARRA   (Spain)

^b NONE

Author keywords

Cirrhosis; Hemodynamic changes; Urinary cyclic GMP

Indexed keywords

CYCLIC GMP;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; HEART OUTPUT; HEMODYNAMICS; HUMAN; HUMAN TISSUE; LIVER CIRRHOSIS; PRIORITY JOURNAL; SODIUM EXCRETION; URINARY EXCRETION; URINE LEVEL; VASCULAR RESISTANCE; VASODILATATION;

ATRIAL NATRIURETIC FACTOR; CASE-CONTROL STUDIES; CYCLIC GMP; FEMALE; HEMODYNAMIC PROCESSES; HUMANS; LIVER CIRRHOSIS, ALCOHOLIC; MALE; MIDDLE AGED; NATRIURESIS; NEUROTRANSMITTER AGENTS; REGRESSION ANALYSIS; SUBSTANCE P;

EID: 0030789161     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1018846122586     Document Type: Article

References (39)

1. Schrier RW, Arroyo V, Bernardi M, Epstein M, Henriksen JH, Rodés J: Peripheral arterial vasodilation hypothesis. A proposal for the initiation of renal sodium retention and water retention. J Hepatol 6:239-257, 1987
2. Vallance P, Moncada S: Hyperdynamic circulation in cirrhosis: A role for nitric oxide? Lancet 337:776-778, 1991
3. Burton GA, MacNeil S, De Jonge-A, Haylor J: Cyclic GMP release and vasodilatation induced by EDRF and atrial natriuretic factor in the isolated perfused kidney of the rat. Br J Pharmacol. 99:364-368, 1990
4. Niederberger, Martin PY, Ginés P, Morris K, Tsai Ph, Li Xu D, McMurtry I, Schrier RW: Normalization of nitric oxide production corrects arterial vasodilation and hyperdynamic circulation in cirrhotic rats. Gastroenterology 109:1624-1630, 1995
5. Niederberger, M Ginés P, Martin PY, Tsai Ph, Morris K, McMurtry I, Schrier RW: Comparison of vascular nitric oxide production and systemic hemodynamics in cirrhosis versus prehepatic portal hypertension in rats. Hepatology 24:947-951, 1996
6. Schneider F, Lutun P, Couchot A, Bilbault P, Tempe JD: Plasma cyclic guanosine 3′-5′ monophosphate concentrations and low vascular resistance in human septic shock. Intensive Care Med 19:99-104, 1993
7. Schneider F, Lutun Ph, Boudjema K, Wolf Ph, Tempé JD: In vivo evidence of enhanced guanylyl cyclase activation during the hyperdynamic circulation of acute liver failure. Hepatology 19:38-44, 1994
8. Dussaule JC, Grange JD, Wolf JP, Lecomte JM, Gros C, Schwartz JC, Bodin F, Ardaillou R: Effect of sinorphan, an enkephalinase inhibitor, on plasma atrial natriuretic factor and sodium urinary excretion in cirrhotic patients with ascites. J Clin Endocrinol Metab 72:653-659, 1991
9. Tajiri K, Miyakawa H, Izumi N, Marumo F, Sato C: Systemic hypotension and diuresis by L-arginine in cirrhotic patients with ascites: Role of nitric oxide. Hepatology 22:1430-1435, 1995
10. Moncada S, Palmer RMJ, Higgs EA: Nitric oxide: Physiology, pathophysiology and pharmacology. Pharmacol Rev 43:109-142, 1991
11. Fernández-Rodriguez CM, Prieto J, Zozaya JM, Quiroga J, Guitián R: Arteriovenous shunting, hemodynamic changes and renal sodium retention in liver cirrhosis. Gastroenterology 104:1139-1145, 1993
12. Fernández-Rodriguez CM, Andrade A, Quiroga J, Zozaya JM, Rodriguez-Martinez D, Prieto J: ANF in liver cirrhosis: Relationship to renal function and hemodynamic changes. 21:211-216, 1994
13. Fernández-Rodriguez CM, Prieto J, Quiroga J, Zozaya JM, Andrade A, Núñez M, Sangro B, Penas J: Plasma levels of substance P in liver cirrhosis: Relationship to the activation of vasopressor systems and urinary sodium excretion. Hepatology 21:35-40, 1995
14. Clariá J, Jimenez W, Ros J, Asbert M, Castro A, Arroyo V, Rivera F, Rodés J: Pathogenesis of arterial hypotension in cirrhotic rats with ascites: Role of endogenous nitric oxide. Hepatology 15:343-349, 1992
15. Huang CL, Ives HE, Cogan MG: In Vivo evidence that cGMP is the second messenger for atrial natriuretic factor. Proc Natl Acad Sci USA 83:8015-8018, 1986
16. Kanno K, Hirata Y, Emori T, Ohta K, Eguchi S, Imai T, Marumo FL: Arginine infusion induces hypotension and diuresis/natriuresis with concomitant increased urinary excretion of nitrite/nitrate and cyclic GMP in humans. Clin Exp Pharmacol Physiol 19:619-625, 1992
17. Warner L, Skorecki K, Blendis LM, Epstein M: Atrial natriuretic factor and liver disease. Hepatology 17:500-513, 1993
18. Clavell AL, Stingo AJ, Wei CM, Heublein DM, Burnett JCJ: C-type natriuretic peptide: A selective cardiovascular peptide. Am J Physiol 264:R290-R295, 1993
19. Furuya M, Takehisa M, Minamitake Y, Kitajima Y, Hayashi Y, Ohnuma N, Ishihara T, Minamino N, Kangawam K, Matsuo H: Novel natriuretic peptide, CNP, potently stimulates cyclic GMP production in rat cultured vascular smooth muscle cells. Biochem Biophys Res Commun 170:201-208, 1990
20. Hirata Y, Matsuoka H, Suzuki E, Hayakawa H, Sugimoto T, Matsuda Y, Morishita Y, Kangawa K, Minamino N, Matsuo H, et al: Role of endogenous atrial natriuretic peptide in DOCA-salt hypertensive rats. Effects of a novel nonpeptide antagonist for atrial natriuretic peptide receptor. Circulation 87:554-561, 1993
21. La Villa G, Romanelli RG, Raggi VC, et al: Plasma levels of brain natriuretic peptide in patients with cirrhosis. Hepatology 16:156-161, 1992
22. Yoshimura M, Yasue H, Morita E, et al: Hemodynamic, renal and hormonal responses to brain natriuretic peptide infusion in patients with congestive heart failure. Circulation 84:1581-1588, 1991
23. Wong F, Blendis L: Pathophysiology of sodium retention and ascites formation in cirrhosis: Role of atrial natriuretic factor. Semin Liver Dis 14:59-70, 1994
24. Horio T, Kohno M, Takeda T: Cosecretion of atrial and brain natriuretic peptides stimulated by endothelin-1 from cultured rat atrial and ventricular cardiocytes. Metabolism 42:94-96, 1993
25. Castro A, Jimenez W, Clariá J, Ros J, Martínez JM, Bosch M, Arroyo V, et al: Impaired responsiveness to angiotensin II in experimental cirrhosis: Role of nitric oxide. Hepatology 18:367-372, 1993
26. Ros J, Jimenez W, Lamas S, Claria J, Arroyo V, Rivera F, Rodes J: Nitric oxide production in arterial vessels of cirrhotic rats. Hepatology 21:554-560, 1995
27. Clariá J, Jimenez W, Ros J, Rigol M, Angeli P, Arroyo V, Rivera F, Rodes J: Increased nitric-oxide-dependent vasorelaxation in aortic rings of cirrhotic rats with ascite. Hepatology 20:1615-1621, 1994
28. Cahill PA, Foster C, Redmon EM, Cingalewski C, Wu Y, Sitzman JV: Enhanced nitric oxide synthase activity in portal hypertensive rabbits. Hepatology 22:598-606, 1995
29. Kanwar S, Kubes P, Tepperman B, Lee SS: Nitric oxide activity in portal-hypertensive and cirrhotic rats. J Hepatol 25:85-89, 1996
30. Fernández M, Garcia-Pagan JC, Casadevall M, Bernadich C, Piera C, Whittle BJ, Pique M, Bosch J, Rodes J: Evidence against a role for inducible nitric oxide synthase in the hyperdynamic circulation of portal-hypertensive rats. Gastroenterology 108:1487-1495, 1995
31. Campillo B, Bories PN, Benvenutti C, Dupeyron C: Serum and urinary nitrate levels in liver cirrhosis: endotoxemia, renal function and hyperdynamic circulation. J Hepatol 24:707-714, 1996
32. Le Moine O, Soupison T, Sogni P, Marchant A, Moreau R, Hadengue A, Goldman M, Devière J, Lebrec D: Plasma endotoxin and tumor necrosis factor-α in the hyperkinetic state of cirrhosis. J Hepatol 23:391-395, 1995
33. Fernández-Rodriguez CM, et al: Circulating TNF-α, hemodynamic, vasoactive and renal function changes in cirrhosis. Gut 37(suppl 2):A24, 1995
34. Sogni P, Moreau R, Gadano A, Lebrec D: The role of nitric oxide in the hyperdynamic circulatory syndrome associated with portal hypertension. J Hepatol 23:218-224, 1995
35. Hörtnagl H, Singer EA, Lenz K, Kleinherger G, Lochs H: Substance P is markedly increased in plasma of patients with hepatic coma. Lancet 1:480-483, 1984
36. Saito R, Nonaka S, Konishi H, Takano Y, Shimohigashi Y, Matsumoto H, Ohno M, Kamiya HO: Pharmacological properties of the tachykinin receptor subtype in the endothelial cell and vasodilation. Ann NY Acad Sci 632:457-459, 1995
37. Schini VB, Katusic ZS, Vanhoutte PM: Neurohypophyseal peptides and tachykinins stimulate the production of cyclic GMP in cultured porcine aortic endothelial cells. J Pharmacol Exp Ther 255:994-1000, 1990
38. Bendtsen F, Schifter S, Henriksen JH: Increased circulating calcitonin gene-related peptide in cirrhosis. J Hepatol 12:118-123, 1991
39. Martin Py, Li Xu D, Niederberger M, Weigert A, Tsai P, John J St, Schrier RW: Up-regulation of endothelial constitutive NOS: A major role in the increased NO production in cirrhotic rats. Am J Physiol 270:F494-F499, 1996